# Public Health Wales

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/public-health-wales/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 53.5 |
| Citations | 406,396 |
| City | Cardiff |
| Country | GB |
| Description | Public Health Wales is a research organisation in Cardiff, GB. OpenAlex records 3,240 works and 406,396 citations for it. 772 researchers list it as their most recent affiliation. |
| Homepage | https://phw.nhs.wales/ |
| OpenAlex ID | https://openalex.org/I4210087753 |
| Researchers | 772 |
| ROR ID | https://ror.org/00265c946 |
| Type | healthcare |
| Works | 3,240 |

## University papers

Showing 12 of 16.

- [Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee Osteoarthritis](https://scholariq.org/papers/glucosamine-chondroitin-sulfate-and-the-two-in-combination-for-painful-knee/)
- [Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis](https://scholariq.org/papers/placebo-controlled-trial-of-tofacitinib-monotherapy-in-rheumatoid-arthritis/)
- [Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis](https://scholariq.org/papers/tofacitinib-or-adalimumab-versus-placebo-in-rheumatoid-arthritis/)
- [Tofacitinib versus Methotrexate in Rheumatoid Arthritis](https://scholariq.org/papers/tofacitinib-versus-methotrexate-in-rheumatoid-arthritis/)
- [SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway](https://scholariq.org/papers/sars-cov-2-omicron-is-an-immune-escape-variant-with-an-altered-cell-entry/)
- [Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial](https://scholariq.org/papers/tofacitinib-cp-690-550-in-combination-with-methotrexate-in-patients-with-active/)
- [Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study](https://scholariq.org/papers/tofacitinib-cp-690-550-in-patients-with-rheumatoid-arthritis-receiving/)
- [Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7](https://scholariq.org/papers/recurrent-emergence-of-sars-cov-2-spike-deletion-h69-v70-and-its-role-in-the/)
- [Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis](https://scholariq.org/papers/tofacitinib-in-combination-with-nonbiologic-disease-modifying-antirheumatic/)
- [The links between prenatal stress and offspring development and psychopathology: disentangling environmental and inherited influences](https://scholariq.org/papers/the-links-between-prenatal-stress-and-offspring-development-and-psychopathology/)
- [Distinguishable Epidemics of Multidrug-Resistant <i>Salmonella</i> Typhimurium DT104 in Different Hosts](https://scholariq.org/papers/distinguishable-epidemics-of-multidrug-resistant-i-salmonella-i-typhimurium/)
- [Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study](https://scholariq.org/papers/changes-in-symptomatology-reinfection-and-transmissibility-associated-with-the/)

## University top topics

Showing 8 of 25.

- [Parasitic Infections and Diagnostics](https://scholariq.org/topics/parasitic-infections-and-diagnostics/)
- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)
- [Child Abuse and Trauma](https://scholariq.org/topics/child-abuse-and-trauma/)
- [Health disparities and outcomes](https://scholariq.org/topics/health-disparities-and-outcomes/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Viral gastroenteritis research and epidemiology](https://scholariq.org/topics/viral-gastroenteritis-research-and-epidemiology/)
- [Amoebic Infections and Treatments](https://scholariq.org/topics/amoebic-infections-and-treatments/)
- [Antibiotic Use and Resistance](https://scholariq.org/topics/antibiotic-use-and-resistance/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.